Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stratified and Randomized Multi-center Phase II - to Determine Potential Benefit of Treating Patients With Advanced Colorectal Cancer According to the Intratumoral TS RNA Levels

NCT01212718 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT01212718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01212718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stratified and Randomized Multi-center Phase II - to Determine Potential Benefit of Treating Patients With Advanced Colorectal Cancer According to the Intratumoral TS RNA Levels
Lead sponsor
University of Ulm
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2001
Completion date
September 30, 2010
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biopsy, colorectal cancer, non resectable metastasis, reference lesion, thymidylate synthase quantitation